Location: New York,NY, USA
Company Overview
Imbria Pharmaceuticals is a privately held, clinical stage company developing novel therapies for patients with life-altering cardiometabolic disorders. Our clinical programs are focused on restoring or improving the cell s ability to produce energy in cardiovascular disorders where energetic impairment is a fundamental contributor to symptoms and functional deficits. Our lead investigational product candidate, ninerafaxstat, has completed Phase 2 clinical trials in non-obstructive hypertrophic cardiomyopathy (nHCM), stable angina, and in patients at high risk of developing cardiometabolic heart failure with preserved ejection fraction (pre-HFpEF). In Phase 1 and 2 clinical trials, ninerafaxstat was shown to be well tolerated. Part 2 of our Phase 2 trial, IMPROVE-DiCE, in patients with cardiometabolic HFpEF, is ongoing with topline results expected in early 2025. For additional information, please visit www.imbria.com.
Position Overview
We are seeking a Director Supply Chain who is experienced, highly energetic, and committed to developing and executing the company s supply strategy across all clinical and pre-clinical programs. This individual will be responsible for designing, building and shaping the supply chain capability for future growth into multiple clinical studies and commercial launch. The individual will be responsible supply planning, vendor forecast management, logistics and cross-functional communication.
In addition, the Director Supply Chain will implement cGMP planning tools across all stages of manufacturing to ensure that the CMC team is aligned with the manufacturing strategy at each CDMO. A strong knowledge of cGMP supply and experience working with manufacturing and distribution operations as well as knowledge of cGMP and FDA/EMA guidelines is required.
Responsibilities
Qualifications
We offer a competitive total compensation package and invite you to consider a career with Imbria!